TTRX Turn Therapeutics, Inc.
Turn Therapeutics, Inc. (TTRX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: December 12, 2025 , by Chaudhary Zuraiz .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Chaudhary Zuraiz | See Remarks | Buy | 2,500 | $3.50 | $8.8K | 12,500 | |
| GOLDEN ARTHUR F | Director | Buy | 9,868 | $3.44 | $33.9K | 60,602 | |
| GOLDEN ARTHUR F | Director | Buy | 20,532 | $2.87 | $58.9K | 50,734 | |
| Chaudhary Zuraiz | See Remarks | Buy | 1,000 | $3.29 | $3.3K | 10,000 | |
| Chaudhary Zuraiz | See Remarks | Buy | 1,450 | $2.61 | $3.8K | 9,000 | |
| Chaudhary Zuraiz | See Remarks | Buy | 2,500 | $3.62 | $9.1K | 7,550 | |
| GOLDEN ARTHUR F | Director | Buy | 20,202 | $4.95 | $100.0K | 30,202 | |
| Chesed Abraham | Other | Buy | 14,286 | $4.60 | $65.7K | 1,447,268 | |
| Chaudhary Zuraiz | See Remarks | Buy | 5,050 | $4.95 | $25.0K | 5,050 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.